Clinical Vector Core Team



Subscribe to be notified of changes or updates to this page.

1 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The Clinical Vector Core comprises a multidisciplinary team of engineers, chemists, and biologists who share one mission: to help people with rare and ultra-rare conditions. Our experts bring their talent and passion to the development and manufacturing of adeno-associated virus and lentiviral vectors. CVC senior leaders’ two decades of experience have created a biomedical innovation hub and attracted top talent to their growing team.


Beverly L. Davidson, PhD

Chief Scientific Strategy Officer

Dr. Davidson is a national and international leader in investigating innovative treatments for devastating, currently untreatable neurological diseases.

Johannes C.M. van der Loo, PhD

Core Director

Dr. van der Loo, a leading expert in preclinical and clinical vector production and characterization, directs the Clinical Vector Core with the goal of helping to realize the enormous promise of gene transfer therapy to address unmet medical needs.

Olga Zelenaia, PhD

Director of Quality

Dr. Zelenaia leads the continuous development and improvement of the Clinical Vector Core facilities, processes, compliance, quality management, and documentation systems.

Fabio Vasconcelos Fonseca, ScB, MS, PhD
Quality Control Director
Bernd Hauck, PhD
Director of Manufacturing
Stephanie Meissgeier
Quality Assurance Director
Stacey Piecyk
Administrative Manager
Matthew Rokita, MEng
Senior Director of Operations